Epithelioid sarcoma (ES) is a rare mesenchymal tumor that is divided into 2 types: classic and proximal. To the authors' knowledge, ES has been poorly studied in cytology, with fewer than 50 cases reported to date. The objective of the current study was to analyze the cytological and immunohistochemical information regarding 5 cases of ES.
INTRODUCTION
Epithelioid sarcoma (ES) is a rare soft-tissue malignancy that accounts for <1% of all sarcomas. 1 It first was described by Laskowski in 1961 as aponeurotic sarcoma. 2 In 1970, Enzinger described >60 cases of this neoplasm and named it "epithelioid sarcoma." 3 To the best of our knowledge, proximal ES first was described in 1997 as ES with marked cytologic atypia. 4 Two main types of ES have been identified to date: classic ("distal type" or "conventional type") and proximal. Classic ES is localized mainly in the distal parts of the upper extremities in teenagers and young adults (median age, 30 years). Proximal ES is more rare than the classic form, occurs in older patients (median age, 40 years), and arises predominantly in the proximal area of the extremities and in axial locations (pelvis, perineum, axilla, mediastinum, or genital tract).
Histologically, classic ES is comprised of various percentages of epithelioid cells with abundant eosinophilic cytoplasm as well as of spindle cells. 4, 5 In the proximal form of ES, rhabdoid cells in addition may be present in the majority of cases. It is of key importance to distinguish between these 2 types because proximal ES is associated
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with a more aggressive clinical course, characterized by disease recurrences and metastases. 4, 6 ES may demonstrate loss of expression of one of the SWI/SNF chromatinremodelling complex sub-unit, mainly SMARCB1/INI1, which may be helpful in making an accurate diagnosis.
To our knowledge to date, fewer than 50 ES cases diagnosed using fine-needle aspiration (FNA) have been reported in the literature [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] but only a few 10, 12, 15, 17, 18 were classified as being of classic or proximal type.
In the current study, we have reported our FNA experience with ES in patients who were diagnosed and treated at the Curie Institute and analyzed the data reported in the literature.
MATERIALS AND METHODS
An extensive review of pathology files from 1999 through 2015 allowed us to identify 5 patients with ES for whom FNA was used for diagnosis. In one patient (patient 1), FNA was performed on a metastatic axillary lymph node with previously known histology. In the remaining 4 patients, FNA was used prior to the histological diagnosis.
The patients were 4 females and 1 male and ranged in age from 10 years to 75 years (mean age, 40 years). One patient was diagnosed with ES of the classic type and 4 patients had proximal-type ES. Primary tumors were localized in the groin in 2 cases and one patient each had a primary tumor located in the buttock, flank, and hand.
FNA was performed in the pelvis in 3 patients and in the axillary lymph node and abdominal wall in 1 patient each. All smears were stained using the MayGrunwald-Giemsa and Papanicolaou methods. The cytological diagnosis was ES in 2 cases and sarcoma not otherwise specified in 3 cases.
Final 
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Clinical data regarding the patients in the current study are presented in Table 1 .
RESULTS
One case was classified as classic ES and 4 cases were classified as proximal ES (Fig. 1) .
Smears from the case of classic ES were hypocellular with a hemorrhagic background (Fig. 2) . The cells were loosely cohesive, middle-sized, epithelioid, and oval or occasionally spindle in shape. Nuclei were eccentrically located and regular with dusty chromatin and inconspicuous single or double nucleoli. Occasionally, the cells were binucleated. Cytoplasm was abundant and greyish. Few cells demonstrated erythrophagocytosis or intracytoplasmic vacuoles. Mitotic figures were not noted and background apoptosis was scant.
The smears from the 4 cases of proximal ES were hypercellular. The background was necrotic and contained various amounts of inflammatory cells, primarily lymphocytes and neutrophils. The smears demonstrated a predominance of dispersed neoplastic cells, and loosely cohesive groups of cells were observed focally. Single pseudopapillary structures with a central vascular core were identified in one case (Fig. 3) . In all tumors, the cells were large and epithelioid with abundant cytoplasm and demonstrated medium-grade to high-grade nuclear atypia. Many cells had a plasmacytoid appearance with eccentrically located nuclei. Moreover, cells with conspicuous nucleoli and/or perinuclear cytoplasmic inclusions associated with rhabdoid morphology (Fig. 4) and dispersed binucleated cells were observed in all cases in varying percentages. Stripped nuclei, brisk mitotic Cancer Cytopathology November 2018 activity, and spindle cells also were noted occasionally. Table 1 shows the main cytological features of the studied cases.
With regard to histological materials, all cases were found to have a nodular growth pattern. In all cases, areas of necrosis were identified. Cell morphology was similar to that observed in cytological smears. Pseudopapillary structures detected on cytology in the case from patient 1 also were observed in corresponding histological sections. The smear from the case from patient 2 presented with a pattern of spindle cells with low-grade atypia (fibroma-like) in between areas comprised of large epithelioid cells. Immunohistochemical tests performed on histological sections from biopsy demonstrated the presence of epithelial markers (pan-CK and/or EMA) in 4 cases (3 proximal-type and 1 classic-type ES), and in 1 case of proximal ES the epithelial markers were negative. Only the classic-type case demonstrated CD34 expression and all proximal-type cases were negative for CD34 expression. In 3 proximal-type cases, focal expression of S-100 was identified. SMARCB1/INI1 analysis was performed only in the 4 cases of proximal-type ES. In 2 cases, immunohistochemical loss of SMARCB1/INI1 expression was shown. In cases with positive SMARCB1/INI1 expression, SMARCA2/ BRM and SMARCA4/BRG1 immunohistochemical tests also were performed. In one of the tumors, a loss of SMARCA2/BRM expression was noted (Fig. 5) , whereas in another case SMARCA2/BRM expression was found to be focal. Table 2 shows the immunohistochemical profiles of the studied tumors. In both cases, SMARCA4/BRG1 expression was retained.
In one case with loss of SMARCB1/INI1 expression, point mutation p.Arg53X (c.157C T) in the SMARCB1/ INI1 gene at 22q11 was found. Cancer Cytopathology November 2018 DISCUSSION ES is a rare mesenchymal tumor. The classic type of ES is more common, whereas the proximal type is reported to account for only approximately one-third of all cases. 17 The 2 types differ primarily with regard to their location and clinical course. 5 To the best of our knowledge, the first cytological description of ES was published in 1974 by Ahmed et al. 7 In the following years, several authors described the cytological features of additional cases. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] The majority of these reported on the classic type, and some of the authors did not classify the tumors as belonging to a specific type. Irrespective of the final diagnosis, similar cytological features were observed in most cases. Nearly all authors reported the dominance of hypercellular smears, especially in the proximal type of ES. In some smears, a necrotic background was observed with acute and chronic inflammatory cells. Dispersed neoplastic cells were dominant, followed by loosely cohesive cell clusters.
The main cell population in the majority of cases was formed by large, round, or polygonal cells, in between which spindle cells were observed in some cases. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Only in single cases were spindle cells noted to be the main population. 10 In the majority of cases, the cells had a moderate to abundant amount of cytoplasm. In addition, well-defined cell borders were noted. The nuclei demonstrated little to significant pleomorphism. In a sizeable number of the reports, the nuclei were located eccentrically, which determined the plasmacytoid appearance of the cells, and in some cases the cells were binucleated or multinucleated. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Some cases presented with conspicuous nucleoli. 10, [12] [13] [14] [15] [16] [17] 20 In some cases, rhabdoid cells were identified, but these were dominant in single smears only. 9, 11, 14, 15 In one case, numerous stripped nuclei were observed. 20 Most of the above features were observed in the present study. In addition, pseudopapillary structures with central vascular cores also were observed in one case of the present study. To the best of our knowledge, this feature has not been described previously. With regard to the reported cases, the main morphological differences noted between the classic and proximal types of ES were found to be a higher grade of cellular atypia and the presence of rhabdoid cells in cases of proximal-type ES. The differential diagnosis takes into account several tumors, mostly metastatic carcinomas, malignant melanoma, and other sarcomas with epithelioid cells. 5 ES is distinguished by the frequent development of local disease recurrence and distant metastases. To the best of our knowledge, it also is one of the few sarcomas that often spreads to the lymph nodes. 1, 4 That is why it may be easily confused with carcinoma (ie, squamous cell carcinoma or malignant melanoma metastases). 8, 21 Cytologically, an important differentiating feature between squamous cell carcinoma and ES is the presence of well-defined cell borders with intercellular spaces in the case of ES. Squamous cell carcinoma normally presents with syncytial clusters without intercellular spaces. 8 Amelanotic malignant melanoma can be a serious candidate to consider in the differential diagnosis. 24 In approximately one-half of the cases, CD34 expression is present. 4 ,24 ES can demonstrate ETS-related gene (ERG) expression, but CD31 expression is negative in all cases, which is helpful in differentiating ES from vascular tumors. 25 Normally, no S-100 expression is observed, 4 and to our knowledge it was only in one study to date that S-100 expression was identified in as many as 30% of tumors. 6 ES usually is negative for desmin and the expression of CK5/6 and p63 is infrequent, thereby distinguishing ES from squamous cell carcinoma. In the current series, the expression of epithelial markers was not demonstrated in one case and in the other case S-100 staining was not performed. Moreover, all proximal-type tumors were found to be CD34 negative and 3 tumors were focally positive for S-100. Demonstration of the loss of expression of the SMARCB1/INI1 subunit of the SWI/SNF chromatin-remodeling complex helps to confirm the diagnosis of ES but also can be observed in rhabdoid tumors. This expression is lost in approximately 90% of cases in both proximal-type and distal-type ES. 26 In tumors with retained SMARCB1/INI1 expression, the loss of expression of other proteins from the SWI/SNF complex is observed. 27, 28 In the current series, retained SMARCB1/INI1 expression was observed in one case, and in another case this expression was focal. In the first case, SMARCA2/BRM expression was lost and in the second case it was focal, similar to SMARCB2/INI1. In both cases, SMARCA4/BRG1 expression was retained. ES is a rare soft-tissue sarcoma. The smears are composed of an admixture of epithelioid, oval, spindle, and rhabdoid cells in different proportions. The proximal-type of ES differs from the classic type by the presence of rhabdoid cells and marked nuclear atypia. A specific immunohistochemical profile demonstrating loss of SMARCB1/ INI1 or other proteins from the SWI/SNF complex also may be indicative of this diagnosis. The differential diagnosis includes other tumors containing epithelioid cells such as carcinomas, amelanotic malignant melanoma, malignant mesothelioma, epithelioid malignant peripheral nerve sheath tumor, epithelioid angiosarcoma, alveolar soft part sarcoma, and rhabdoid tumor.
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